Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Not all low-cost index funds support drip, so compare available options and setup steps to automate reinvestment and maximize growth.
26,805 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Kraken has reportedly secured access to the Fed’s core payment systems, a move that could accelerate settlement times...
A major Ethereum Layer-2 network, Taiko, halted block production after an exploit. Blockaid suggests the root cause l...
MTUM has surged on momentum bets early in July, but a rotation out of high-multiple growth could weigh on the fund. T...
As markets wobble, traders watch RSI and other momentum tools to spot oversold stocks. This piece explains what overs...
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...
Constant portfolio checks feel productive, but they often erode long-term gains. Learn why stopping the daily peek ma...
UnitedHealth Group just 52-week highs spark questions about sustainability. This guide breaks down what's driving the...
When headlines warn of a strike and then show diplomacy's glow, oil markets react in real time. This guide outlines s...
Two YieldMax income ETFs tied to Berkshire and Microsoft have seen weekly payouts collapse as market volatility dries...
Retirement opens doors to new communities where healthcare is strong, costs are reasonable, and daily life feels comf...
Oil prices have spiked more than 25% since the conflict began, but oil stocks have barely moved. This guide explains ...